Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

D-3263 HCl may stabilize disease in patients with advanced prostate cancer

Nov. 23, 2010

CTAP-201 shows promise in patients with secondary hyperparathyroidism on hemodialysis

Nov. 23, 2010

First-in-human data presented on OMP-21M18 in solid tumors

Nov. 23, 2010

HM-A42 ameliorates disease symptoms in models of asthma, RA and MS

Nov. 23, 2010

Solithromycin shows potential against Plasmodium spp. and Mycobacterium leprae

Nov. 23, 2010

Promising new antimalarial candidates investigated in preclinical testing

Nov. 22, 2010

Lilly describes activity of LY-2606368, now in phase I testing

Nov. 22, 2010

Apilimod mesilate has limited efficacy in phase II trial in rheumatoid arthritis

Nov. 22, 2010

Proof-of-concept secukinumab trial in ankylosing spondylitis meets primary endpoint

Nov. 19, 2010

AC-430 confers protection in models of autoimmune and inflammatory conditions

Nov. 19, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...